phrykt

Orbimed Advisors Llc: insider trades and track record

As of Nov 10, 2026, Orbimed Advisors Llc filed 20 open-market purchases worth $28.3M and 36 sales worth $68.8M in 11 companies since Apr 19, 2024, from Form 4 filings. At the latest insider trade price in each stock, 15 of 15 purchases are worth more than the price paid (median change +8%).

Latest filing Nov 10, 2026. From Form 4 filings. Data only, not investment advice.

At a glance

Bought, 3 years$28.3M20 purchases
Sold, 3 years$68.8M36 sales
Result on shares bought, then sold–Nothing sold yet
Change on shares still held+$10.1M+124% vs $8.2M paid, at latest insider price
Companies11Where they are an insider

Track record by company

One row per company: what they paid, what they got for shares sold later, and how the shares they still hold compare with the latest insider trade price.

StockRoleBoughtAvg price paidResult on shares soldShares still heldLatest priceChange on held shares
ASPEDirector$15M$15.00–1.00M$15.00 Nov 2, 2026–
ACET split10% owner$5M$8.00–625,000no recent trade–
ETRADirector$4.3M$7.70–564,687$8.45 Nov 10, 2026+10%
MBXDirector$4M$16.00–250,000$54.82 Nov 10, 2026+243%

3.68M shares sold were not bought in the open market in our data (stock awards, options or purchases before Nov 17, 2023), so they have no return.

Every purchase and the latest price

Each open-market purchase, next to the most recent price any insider paid or received for the same stock.

DateStockSharesPrice paidValueLatest priceChange
Nov 10, 2026ETRA20,700$8.45$175Kno later trade–
Nov 10, 2026ETRA2,000$8.45$16.9Kno later trade–
Nov 9, 2026ETRA4,000$8.24$33K$8.45 Nov 10, 2026+3%
Nov 9, 2026ETRA16,000$8.24$132K$8.45 Nov 10, 2026+3%
Nov 6, 2026ETRA9,816$7.85$77.1K$8.45 Nov 10, 2026+8%
Nov 6, 2026ETRA39,600$7.85$311K$8.45 Nov 10, 2026+8%
Nov 5, 2026ETRA30,891$7.31$226K$8.45 Nov 10, 2026+16%
Nov 5, 2026ETRA125,200$7.31$915K$8.45 Nov 10, 2026+16%
Nov 4, 2026ETRA9,267$7.78$72.1K$8.45 Nov 10, 2026+9%
Nov 4, 2026ETRA37,100$7.78$289K$8.45 Nov 10, 2026+9%
Nov 4, 2026ETRA5,000$7.07$35.4K$8.45 Nov 10, 2026+20%
Nov 4, 2026ETRA20,000$7.07$141K$8.45 Nov 10, 2026+20%
Nov 3, 2026ETRA24,313$7.84$191K$8.45 Nov 10, 2026+8%
Nov 3, 2026ETRA97,800$7.84$767K$8.45 Nov 10, 2026+8%
Nov 3, 2026ETRA24,400$7.88$192K$8.45 Nov 10, 2026+7%
Nov 3, 2026ETRA98,600$7.88$777K$8.45 Nov 10, 2026+7%
Nov 2, 2026ASPE1.00M$15.00$15Mno later trade–
Oct 8, 2025ACET1.50M$1.00 ($8.00 adj.)$1.5Mno later trade–
Oct 8, 2025ACET3.50M$1.00 ($8.00 adj.)$3.5Mno later trade–
Sep 16, 2024MBX250,000$16.00$4M$54.82 Nov 10, 2026+243%
How this track record is worked out
  • Only open-market purchases and sales (Form 4 codes P and S) from the last 3 years. Shares received as pay, from options or before that window are not purchases, so they never count toward a return.
  • Result on shares sold matches each sale with this insider's own earlier purchases in the same company, oldest first, using the prices in their filings.
  • Latest price is the price of the most recent open-market trade any insider filed in that company, with its date. It is not a live stock quote, and it is not shown when it is more than 120 days old.
  • Prices are adjusted for stock splits, found when the company's shares outstanding (from its 10-Q and 10-K covers) and the trade prices move by the same split ratio.
  • A trade reported jointly by several owners (a fund, its manager, its partners) is shown once, under the first owner named in the filing.
  • Past results say nothing about future trades. This is a record of filings, not a recommendation.

All open-market trades

Purchases and sales by month for the last 3 years. Click a month to see only its trades.

$51.7M$51.7MDec 23Jun 24Dec 24Jun 25Dec 25Jun 26
Purchases Sales Click a bar to show only that month below
DateStockInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase20,700$8.45$175KForm 4
Nov 10, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase2,000$8.45$16.9KForm 4
Nov 9, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase4,000$8.24$33KForm 4
Nov 9, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase16,000$8.24$132KForm 4
Nov 6, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase9,816$7.85$77.1KForm 4
Nov 6, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase39,600$7.85$311KForm 4
Nov 5, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase30,891$7.31$226KForm 4
Nov 5, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase125,200$7.31$915KForm 4
Nov 4, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase9,267$7.78$72.1KForm 4
Nov 4, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase37,100$7.78$289KForm 4
Nov 4, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase5,000$7.07$35.4KForm 4
Nov 4, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase20,000$7.07$141KForm 4
Nov 3, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase24,313$7.84$191KForm 4
Nov 3, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase97,800$7.84$767KForm 4
Nov 3, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase24,400$7.88$192KForm 4
Nov 3, 2026ETRAOrbimed Advisors Llc +2DirectorPurchase98,600$7.88$777KForm 4
Nov 2, 2026ASPEOrbimed Advisors Llc +1DirectorPurchase1.00M$15.00$15MForm 4
Jun 22, 2026ELVNOrbimed Advisors Llc +210% ownerSale24,846$45.38$1.1MForm 4
Jun 22, 2026ELVNOrbimed Advisors Llc +210% ownerSale46,776$45.00$2.1MForm 4
Jun 22, 2026ELVNOrbimed Advisors Llc +210% ownerSale787,024$45.38$35.7MForm 4
Jun 22, 2026ELVNOrbimed Advisors Llc +210% ownerSale1,477$45.00$66.5KForm 4
Jun 15, 2026ELVNOrbimed Advisors Llc +210% ownerSale9,086$45.02$409KForm 4
Jun 15, 2026ELVNOrbimed Advisors Llc +210% ownerSale272,322$45.02$12.3MForm 4
Nov 26, 2025SIONOrbimed Advisors Llc +1DirectorSale plan1,600$44.49$71.2KForm 4
Nov 25, 2025SIONOrbimed Advisors Llc +1DirectorSale plan11,890$44.60$530KForm 4
Nov 24, 2025SIONOrbimed Advisors Llc +1DirectorSale plan94,583$44.54$4.2MForm 4
Oct 8, 2025ACETOrbimed Advisors Llc +710% ownerPurchase1.50M$1.00$1.5MForm 4
Oct 8, 2025ACETOrbimed Advisors Llc +710% ownerPurchase3.50M$1.00$3.5MForm 4
Sep 10, 2025PMVPOrbimed Advisors Llc +110% ownerSale500,000$1.80$900KForm 4
Jun 27, 2025CRVSOrbimed Advisors Llc +1DirectorSale1.18M$4.16$4.9MForm 4
Jun 26, 2025PASGOrbimed Advisors Llc +110% ownerSale213,257$0.33$70.4KForm 4
Jun 25, 2025PASGOrbimed Advisors Llc +110% ownerSale138,800$0.33$45.8KForm 4
Jun 24, 2025PASGOrbimed Advisors Llc +110% ownerSale231,600$0.35$81.1KForm 4
May 14, 2025NPCEOrbimed Advisors Llc +110% ownerSale34,000$15.94$542KForm 4
May 14, 2025NPCEOrbimed Advisors Llc +110% ownerSale134,136$15.83$2.1MForm 4
Apr 24, 2025PASGOrbimed Advisors Llc +110% ownerSale68,195$0.32$21.8KForm 4
Apr 23, 2025PASGOrbimed Advisors Llc +110% ownerSale89,328$0.34$30.4KForm 4
Apr 22, 2025PASGOrbimed Advisors Llc +110% ownerSale78,049$0.34$26.5KForm 4
Jan 14, 2025PASGOrbimed Advisors Llc +110% ownerSale79,024$0.60$47.4KForm 4
Jan 13, 2025PASGOrbimed Advisors Llc +110% ownerSale17,986$0.64$11.5KForm 4
Jan 10, 2025PASGOrbimed Advisors Llc +110% ownerSale126,209$0.66$83.3KForm 4
Dec 11, 2024PASGOrbimed Advisors Llc +110% ownerSale80$0.80$64Form 4
Dec 10, 2024PASGOrbimed Advisors Llc +110% ownerSale8,015$0.80$6.4KForm 4
Dec 9, 2024PASGOrbimed Advisors Llc +110% ownerSale54,181$0.84$45.5KForm 4
Sep 19, 2024PASGOrbimed Advisors Llc +110% ownerSale39,300$0.71$27.9KForm 4
Sep 16, 2024MBXOrbimed Advisors Llc +2DirectorPurchase250,000$16.00$4MForm 4
Jul 2, 2024TELAOrbimed Advisors Llc +110% ownerSale36,600$4.54$166KForm 4
Jul 1, 2024TELAOrbimed Advisors Llc +110% ownerSale13,700$4.68$64.1KForm 4
Jun 28, 2024TELAOrbimed Advisors Llc +110% ownerSale378,000$4.74$1.8MForm 4
May 3, 2024NPCEOrbimed Advisors Llc +110% ownerSale4,674$14.03$65.6KForm 4
May 2, 2024NPCEOrbimed Advisors Llc +110% ownerSale8,842$14.01$124KForm 4
May 1, 2024NPCEOrbimed Advisors Llc +110% ownerSale15,690$14.02$220KForm 4
Apr 24, 2024NPCEOrbimed Advisors Llc +110% ownerSale1,781$14.06$25KForm 4
Apr 23, 2024NPCEOrbimed Advisors Llc +110% ownerSale21,791$14.29$311KForm 4
Apr 22, 2024NPCEOrbimed Advisors Llc +110% ownerSale24,609$14.05$346KForm 4
Apr 19, 2024NPCEOrbimed Advisors Llc +110% ownerSale18,253$14.02$256KForm 4

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.